Rankings
▼
Calendar
DYN Q3 2017 Earnings — Dyne Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
DYN
Dyne Therapeutics, Inc.
$3B
Q3 2017 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$182M
-24.5% YoY
Gross Profit
-$605M
-332.4% margin
Operating Income
$58M
31.9% margin
Net Income
-$133M
-73.1% margin
EPS (Diluted)
$-0.82
QoQ Revenue Growth
+0.6%
Cash Flow
Operating Cash Flow
$271M
Free Cash Flow
$271M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$12.0B
Total Liabilities
$10.0B
Stockholders' Equity
$2.0B
Cash & Equivalents
$613M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$182M
$241M
-24.5%
Gross Profit
-$605M
-$419M
-44.4%
Operating Income
$58M
-$117M
+149.6%
Net Income
-$133M
-$249M
+46.6%
← FY 2017
All Quarters
Q4 2017 →